Faced with High Cost Sharing for Brand Medicines, Many Commercially Insured Patients with Chronic Conditions Use Manufacturer Cost-Sharing Assistance

Teaser image for a PhRMA-commissioned report from IQVIA on out of pocket spending among commercially insured patients with chronic conditions

Out-of-pocket spending for prescription medicines a decade ago consisted almost entirely of copays, but use of deductibles and coinsurance in commercial health insurance has skyrocketed in recent years. This shift has resulted in many patients with chronic conditions being asked to pay a larger share of the cost of their medicines.

Teaser image for a PhRMA-commissioned report from IQVIA on out of pocket spending among commercially insured patients with chronic conditions

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.